Blog

Get involved in the research

dark stormy night with moon light coming through clouds

At Apollo Neuro, we hold ourselves to the best practices and the highest standards in current scientific methodology. Browse our collection of scientific studies featuring the Apollo wearable on topics such as sleep, cardiovascular health, focus, burnout, and more, and learn more about our approach to science and research 鈥 including our five science principles.

Recruitment opportunities

The following studies are open for eligible participants. Review the eligibility criteria before taking the screen survey. If there isn鈥檛 the right study opportunity for you at the moment, check back soon. We currently have 14 clinical studies underway, and our research department is only getting more robust. Thanks for your interest and we鈥檙e looking forward to being in touch.

1. Long Covid

  • Overview: The purpose of this study is to examine the effects of consistent Apollo wearable use on quality of life and symptoms related to post-acute sequelae SARS-CoV-2 infection (PASC), commonly known as Long Covid.
  • Eligibility to join:
    • Age 18 or over
    • Participants must be currently experiencing post-COVID symptoms in at least one of the following areas: Respiratory-related symptoms, fatigue-related symptoms, neurologic-related symptoms, psychiatric-related symptoms, sleep-related symptoms, change in quality of life/functional status
    • Must be new purchasers of Apollo who haven鈥檛 started using their Apollo device or previous users of Apollo who haven鈥檛 used Apollo in the preceding 14 days.
  • Exclusion criteria:
    • Inability to use or access a compatible Android or iOS smartphone
    • Are unable to complete consent and questionnaires written in English
    • Current resident of a European Union (EU) country
  • Sponsor: The Board of Medicine
  • Sample Size: Up to 200 participants
  • Compensation: Research will be conducted at no cost to the subject participating. Participants will not be compensated additionally for their time.
  • Clinical trial coming soon.
Take the screener survey
Right Arrow Icon.

2. Open-Label Clinical Trial of Apollo to Sustain Remission in Treatment-Resistant PTSD following MDMA-Assisted Psychotherapy

  • Overview: The purpose of this study is to examine a treatment model for tuned vibroacoustic stimulation (TVS), an exteroceptive cue that has been shown to reduce subjective and physiological indicators of stress and increase behavioral performance. This study will test whether TVS delivered through the Apollo system improves rates of sustained symptom remission in PTSD following MDMA-assisted psychotherapy over the course of two years.
  • Eligibility:
    • Age 18 or over
    • Participants must also meet one of the following:
      • completion of the MAPS MDMA-Assisted Psychotherapy for PTSD clinical trial (treatment cohort)
      • completion of the MAPS MDMA-Assisted Psychotherapy for PTSD clinical trial (placebo cohort)
      • enrolled in the MAPS MDMA-Assisted Psychotherapy for PTSD clinical trial, but dropped out
  • Exclusion criteria:
    • Are not able to give adequate informed consent
    • Have any current problem which, in the opinion of the investigator might interfere with participation
    • Are unable to complete questionnaires written in English. The justification is that many of the primary analyses involve assessment of change in self-reported symptoms using measures normed in English. Participants must thus be able to read those measures to give valid indications of the extent to which they have responded to the intervention.
  • Sponsor: Apollo Neuroscience, Inc.
  • Sample Size: 200 participants
Take the screener survey
Right Arrow Icon.

3. Apollo Sleep Study

  • Overview: The purpose of this research is to examine whether or not Apollo Neuro improves sleep and cardiovascular function in a diverse real-world population. Apollo Neuro emits gentle vibrations found to benefit mood, energy, and focus.
  • Eligibility:
    • Ages 18 and up
    • Use both the Apollo Neuro and Oura Ring Devices.
  • Exclusion criteria:
    • Inability to complete questionnaires written in English.
  • Sponsor: Apollo Neuroscience, Inc.
  • Sample Size: Up to 6000 participants
  • Timeline: include messaging that they will hear from us when we open the next cohort
  • See clinical trial
Take the screener survey
Right Arrow Icon.

A note on privacy: We take privacy and confidentiality very seriously. We will never share your private and identifiable information with anyone. You can discontinue your participation at any time.